Medtronic PLC (NYSE:MDT)

The financial performance over the six-year period is characterized by a persistent negative economic profit, indicating that the company has consistently failed to generate operating returns that exceed its cost of capital.

Net Operating Profit After Taxes (NOPAT)

NOPAT exhibits significant volatility, reaching a period low of 3,736 million US$ in 2024 before rebounding to a period high of 4,980 million US$ in 2025. While there was a temporary peak in 2022, the overall trend shows a fluctuations that directly impact the entity's ability to cover its capital charges.

Capital Investment and Cost of Capital

The cost of capital remained relatively stable, fluctuating within a narrow range between 12.43% and 12.96%. Similarly, invested capital showed no definitive long-term growth or contraction trend, oscillating between a low of 68,670 million US$ in 2024 and a high of 72,405 million US$ in 2021. The relative stability of these metrics suggests that the volatility in economic profit is driven primarily by operating performance rather than changes in the cost of funding or the scale of the asset base.

Economic Profit Trends

Economic profit remained negative throughout the entire observed period, with the most significant value destruction occurring in 2021 at -5,336 million US$. A partial recovery is noted in 2025, where the economic profit reached its least negative value of -3,768 million US$. The persistent negative values indicate that the return on invested capital has remained below the required threshold, resulting in a continuous erosion of economic value.

Net Income Attributable to Medtronic

The net income figures demonstrated variability over the reported periods. Starting at 4,789 million US dollars in April 2020, the net income decreased significantly to 3,606 million by April 2021. It rebounded to 5,039 million in April 2022, indicating a strong recovery. However, a subsequent decline occurred, with net income falling to 3,758 million in April 2023 and slightly decreasing again to 3,676 million in April 2024. The latest period, April 2025, shows an improvement to 4,662 million, suggesting a positive turnaround in profitability.

Net Operating Profit After Taxes (NOPAT)

NOPAT followed a somewhat similar pattern to net income, but with slightly less fluctuation. It decreased from 4,408 million in April 2020 to 4,049 million in April 2021. Then, it increased again to 4,888 million by April 2022. Thereafter, it declined to 4,151 million in April 2023 and further down to 3,736 million in April 2024. The most recent figure in April 2025 reached 4,980 million, representing the highest value among the periods analyzed and indicating improved operational profitability.

Overall Trend Analysis

Both net income and NOPAT exhibited cyclical patterns with notable decreases in 2021 and 2023-2024, followed by recoveries in 2022 and 2025. The volatility suggests the company faced varying operational and market challenges throughout the periods. The recent rise in both metrics in 2025 points towards an enhanced financial performance and operational efficiency. Furthermore, the highest NOPAT value in the final period underscores an improvement in profitability after taxes on operating income, which is a positive indicator for core business performance.

The financial data reveals notable trends in the tax-related expenses over the observed period.

Income Tax Provision (Benefit)

The income tax provision shows significant fluctuations from 2020 to 2025. Initially, in 2020, there was a tax benefit of -$751 million, indicating a negative tax provision. However, from 2021 onwards, there is a reversal to positive tax provisions, increasing from $265 million in 2021 to a peak of $1,580 million in 2023. Thereafter, the provision decreases to $1,133 million in 2024 and further to $936 million in 2025. This pattern suggests an initial tax advantage followed by growing tax liabilities that begin to moderate in the final years of the period.

Cash Operating Taxes

Cash operating taxes demonstrate a consistent upward trend throughout the period from 2020 to 2023, increasing from $761 million to $1,979 million. In 2024, there is a slight decline to $1,820 million, followed by a further decrease to $1,436 million in 2025. This rise and subsequent decline in cash taxes could reflect operational performance fluctuations or changes in tax strategies and cash management.

Overall, the data indicates evolving tax expenses with an initial tax benefit turning into substantial tax provisions and an increasing trend in cash operating taxes until 2023, followed by a moderate decline in the last two reporting periods.

The financial data shows several notable trends over the six-year period under review.

Total reported debt & leases

The total reported debt and leases have generally increased, growing from 25,742 million US dollars in April 2020 to 29,626 million US dollars in April 2025. Despite some fluctuations, such as a decrease in 2022, the overall trend is upward, indicating a gradual rise in leverage or financing through debt and leases.

Shareholders’ equity

Shareholders’ equity experienced a slight increase from 50,737 million US dollars in April 2020 to a peak of 52,551 million US dollars in April 2022. However, from that peak, equity declined steadily to 48,024 million US dollars by April 2025. This downward trajectory in equity may reflect distributions to shareholders, asset impairments, or other factors reducing net asset value.

Invested capital

Invested capital saw a modest increase from 71,146 million US dollars in April 2020 to a peak near 72,405 million US dollars in April 2021. Subsequently, it declined to a low of 68,670 million US dollars in April 2024 before rising again to 70,365 million US dollars in April 2025. This pattern suggests some variability in the company's capital investment or asset base, with a general trend of moderate fluctuation rather than sustained growth or contraction.

Medtronic PLC has consistently reported negative economic profit and a negative economic spread ratio throughout the period from April 2020 to April 2025. This indicates that the return on invested capital has remained below the company's cost of capital, resulting in the destruction of economic value over the observed timeframe.

Economic Profit Trends

Economic profit remained negative across all six years, reaching its lowest point in April 2021 with a deficit of US$ 5,336 million. While losses persisted, a trend of improvement is observable toward the end of the period, with the deficit narrowing to US$ 3,768 million by April 2025, the strongest performance in the analyzed sequence.

Invested Capital Stability

Invested capital remained relatively stable, fluctuating within a narrow range between US$ 68,670 million in 2024 and US$ 72,405 million in 2021. This stability suggests that the fluctuations in economic profit are not the result of significant changes in the capital base, but rather stem from variations in the returns generated on that capital relative to its cost.

Economic Spread Ratio Analysis

The economic spread ratio reflects a consistent failure to exceed the cost of capital, with values ranging from a low of -7.37% in 2021 to a high of -5.35% in 2025. The ratio shows significant volatility between 2021 and 2024, followed by a notable recovery in 2025, indicating a reduction in the gap between the return on capital and the required rate of return.

An analysis of the financial performance from April 2020 to April 2025 reveals a persistent trend of negative economic profit, indicating that the entity did not generate returns in excess of its cost of capital during this period. However, there is observable evidence of recovery and margin improvement toward the end of the timeframe.

Economic Profit Trajectory

Economic profit exhibited significant volatility, reaching its lowest point in April 2021 at -5,336 million USD. Subsequent years showed fluctuations, with a notable recovery in April 2022 before declining again in 2023 and 2024. By April 2025, economic profit improved to -3,768 million USD, marking the strongest performance within the observed period.

Adjusted Net Sales Growth

A consistent upward trend in adjusted net sales is observed, growing from 28,901 million USD in April 2020 to 33,530 million USD by April 2025. Except for a slight contraction in April 2023, the revenue stream expanded steadily, providing a growing base for potential value creation.

Economic Profit Margin Performance

The economic profit margin remained negative throughout the six-year period, fluctuating between a low of -17.68% in 2021 and a high of -11.24% in 2025. The margin experienced a sharp improvement in 2022, followed by a regression in 2023, and a subsequent steady climb toward the period's peak in 2025. This suggests a gradual narrowing of the gap between actual returns and the required cost of capital.

The convergence of increasing adjusted net sales and a narrowing negative economic profit margin indicates a positive shift in the organization's ability to manage its capital efficiency, although the entity has yet to achieve a positive economic profit state.